Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Oncovir, Inc.
Information provided by (Responsible Party):
Regina Jakacki, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00795457
First received: November 19, 2008
Last updated: May 27, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2014
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)